Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1965 May;8(5):484-98.

The antibacterial effect of Bordetella pertussis antisera

The antibacterial effect of Bordetella pertussis antisera

J M Dolby. Immunology. 1965 May.

Abstract

Antisera to Bordetella pertussis are bactericidal for some strains of B. pertussis in the presence of complement and lysozyme. Phase I bacilli, virulent for mice by the intracerebral and intranasal routes, are sensitive to the bactericidal effect; most mouse avirulent strains are not.

Most of the bactericidal antisera belong to one of two types according to the concentration of antibody and complement that are optimally lethal. Type 1 antisera are bactericidal in the range 1/30 to 1/900 with guinea-pig serum as the complement source at 1/18 to 1/100. Type 2 antisera are characterized by a zone without bactericidal activity over similar antiserum and complement dilutions. Their bactericidal activity is made evident by diluting the antiserum further, by increasing the amount of complement, or by adding tissue homogenates, body fluids or crystalline lysozyme. The two types are further characterized by the differing requirements of the bactericidal system for the individual components of haemolytic complement.

The combined lethal action of antibody, complement and lysozyme is rapid. In the early stages it is partly inhibited by substances in the medium used for estimating viable counts indicating that in its initial stages the reaction is bacteriostatic rather than bactericidal.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1953 Jan;70(1):69-78 - PubMed
    1. J Immunol. 1954 Dec;73(6):426-34 - PubMed
    1. Proc Soc Exp Biol Med. 1960 Jan;103:250-2 - PubMed
    1. J Bacteriol. 1961 Mar;81:492-9 - PubMed
    1. J Immunol. 1956 Jan;76(1):11-9 - PubMed

LinkOut - more resources